Abstract:Abstract Background Wilms tumour (WT) is a mixed type of embryonal tumour that usually occurs in early childhood. However, our knowledge of the pathogenesis or progression mechanism of WT is inadequate, and there is a scarcity of beneficial therapeutic strategies. Methods High-throughput RNA sequencing was employed in this study to identify differentially expressed genes (DEGs) in clinical tumor samples and matching normal tissues. The STRING database was utilized to build a protein-protein interaction (PPI) network, and the Cytohubba method was used to identify the top 10 highly related HUB genes. Then, the key genes were further screened by univariate COX survival analysis. Subsequently, the xCELL algorithm was used to evaluate the tumour immune infiltration. RT-PCR, WB, and IF were used to verify the expression level of key genes in clinical tissues and tumour cell lines. Finally, the function of the key gene was further verified by loss-of-function experiments. Results We initially screened 1612 DEGs, of which 1030 were up-regulated and 582 were down-regulated. The GO and KEGG enrichment analysis suggested these genes were associated with ‘cell cycle’, ‘DNA replication’. Subsequently, we identified 10 key HUB genes, among them CCNB1 was strongly related to WT patients' overall survival. Multiple survival analyses showed that CCNB1 was an independent indicator of WT prognosis. Thus, we constructed a nomogram of CCNB1 combined with other clinical indicators. Single gene GSEA and immune infiltration analysis revealed that CCNB1 was associated with the degree of infiltration or activation status of multiple immune cells. TIDE analysis indicated that this gene was correlated with multiple key immune checkpoint molecules and TIDE scores. Finally, we validated the differential expression level of CCNB1 in an external geneset, the pan-cancer, clinical samples, and cell lines. CCNB1 silencing significantly inhibited the proliferation, migration, and invasive capabilities of WIT-49 cells, also, promoted apoptosis, and in turn induced G2 phase cell cycle arrest in loss-of-function assays. Conclusion Our study suggests that CCNB1 is closely related to WT progression and prognosis, and serves as a potential target.

The Tumor Suppressor WTX Shuttles to the Nucleus and Modulates WT1 Activity.

Wilms Tumor Gene on X Chromosome (WTX) Inhibits Degradation of NRF2 Protein Through Competitive Binding to KEAP1 Protein.

WT1 Mutation As a Cause of 46 XY DSD and Wilm’s Tumour: a Case Report and Literature Review

Role of the Wilms' Tumor 1 Gene in the Aberrant Biological Behavior of Leukemic Cells and the Related Mechanisms.

The Wilms' Tumor 1 Gene: Oncogene or Tumor Suppressor Gene?

Gsk3 Beta-Mediated Expression Of Cug-Translated Wt1 Is Critical For Tumor Progression

CCNB1 is a Novel Prognostic Biomarker and Promotes Proliferation, Migration and Invasion in Wilms Tumor.

WT1 Promotes Invasion of NSCLC Via Suppression of CDH1

Wilms' Tumor 1 And Signal Transducers And Activators Of Transcription 3 Synergistically Promote Cell Proliferation: A Possible Mechanism In Sporadic Wilms' Tumor

WT1 promotes invasion of NSCLC via suppression of CDH1.

The Expression and Potential Role of Tubulin Alpha 1b in Wilms’ Tumor

Long Non-coding Wilms Tumor 1 Antisense RNA in the Development and Progression of Malignant Tumors

The role of WT1 in breast cancer: clinical implications, biological effects and molecular mechanism

Twa1/Gid8 is a Β-Catenin Nuclear Retention Factor in Wnt Signaling and Colorectal Tumorigenesis

The Antitumor Activity Of Tcr-Mimic Antibody-Drug Conjugates (Tcrm-Adcs) Targeting The Intracellular Wilms Tumor 1 (Wt1) Oncoprotein

Investigating the Dysfunctional Pathogenesis of Wilms' Tumor Through a Multidimensional Integration Strategy.

Altered binding affinity of SIX1-Q177R correlates with enhanced WNT5A and WNT pathway effector expression in Wilms tumor

Long Non-Coding RNA XIST Promotes Wilms Tumor Progression Through the Mir-194-5p/yap Axis.

Nuclear degradation of Wilms tumor 1-associating protein and survivin splice variant switching underlie IGF-1-mediated survival

Cyclin B1 is a Novel Prognostic Biomarker and Promotes Proliferation, Migration and Invasion in Wilms Tumour

HnRNPL Promotes Wilms Tumor Progression by Regulating the P53 and Bcl2 Pathways.